Related Experiment Video
Updated: Mar 13, 2026

Capture and Release of Viable Circulating Tumor Cells from Blood
Published on: October 28, 2016
Comparison and optimization of machine learning methods for automated classification of circulating tumor cells
Timothy B Lannin1, Fredrik I Thege2, Brian J Kirby3,4
1Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY, U.S.A.
Automating circulating tumor cell (CTC) detection using machine learning (ML) significantly speeds up analysis and improves accuracy. Comparing four ML algorithms on diverse datasets highlights the need for dataset-specific optimization for reliable rare cell analysis.
Area of Science:
- Biotechnology
- Medical Diagnostics
- Computational Biology
Background:
- Rare cell capture technology enables circulating tumor cell (CTC) analysis from patient blood.
- Manual cell counting is a bottleneck, being time-consuming, inconsistent, and prone to bias.
Purpose of the Study:
- To automate the location and classification of captured cells using machine learning (ML).
- To explore the impact of different ML algorithms on rare cell detection performance.
Main Methods:
- Trained four ML algorithms on three distinct datasets.
- Evaluated algorithm performance based on speed and accuracy (Area Under the ROC Curve).
Main Results:
- ML algorithms processed thousands of cells in minutes, a significant speed increase over manual methods.
- Some ML algorithms demonstrated superior performance (P < 0.05) compared to others.
- Training and testing discrepancies between cell lines and CTCs indicate a need for representative training data.
Conclusions:
- Automated ML approaches dramatically enhance rare cell detection efficiency and consistency.
- Algorithm selection and optimization are crucial and dataset-dependent for accurate rare cell classification.
- Future work should focus on training ML models with data representative of real-world clinical samples.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
14:14Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014